Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ENSTILAR (bétaméthasone (dipropionate de)/ calcipotriol monohydraté)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ENSTILAR (bétaméthasone (dipropionate de)/ calcipotriol monohydraté)

Medicine - Posted on Apr 30 2021
Active substance (DCI)
  • bétaméthasone
  • calcipotriol
history (3)
  • 4/7/21

    ENSTILAR (calcipotriol, bétaméthasone)

    Modifications de l’AMM. Avis favorable au maintien du remboursement dans le traitement topique du psoriasis vulgaire de l’ad...
    icône flèche
  • 4/7/21

    ENSTILAR (calcipotriol, bétaméthasone)

    Mise à disposition d’une nouvelle présentation. Avis favorable au remboursement dans le traitement topique du psoriasis vulg...
    CAV :
    54321
    icône flèche
  • 10/25/17

    ENSTILAR (calcipotriol, betamethasone), antipsoriatic

    Minor improvement in efficacy compared with DAIVOBET and XAMIOL in the treatment of psoriasis. ENSTILAR, in a cutaneous foam...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • D05AX52
Manufacturer
LEO PHARMA
Presentation

ENSTILAR 50 microgrammes/0,5mg/g, mousse cutanée (code CIS : 67347855) - 1 flacon(s) pressurisé(s) aluminium de 60 g (CIP : 34009 300 749 8 5) - 2 flacon(s) pressurisé(s) aluminium de 60 g (CIP : 34009 300 749 9 2)

All our publications
    Drug therapy Skin and connective tissue diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
u4vsTr7FNT3FKmkq